EUVIMEDEUVIMED entdecken
Crossref

L26/P-415 Association between ovarian stromal fibrosis and prior anti-tumor therapy in cryopreserved ovarian tissue

S. Iyoshi, N. Miyake, H. Fujimoto, C. Kamiya, T. Shibata, H. Akita, K. Kawai, M. Ueda, K. Furui, T. Takeda, T. Seki, S. Reina und 3 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Iyoshi und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is prior exposure to chemotherapy or radiotherapy associated with increased ovarian stromal fibrosis in cryopreserved ovarian tissue? Summary answer Ovarian stromal fibrosis was significantly increased after anti-tumor therapy, even in younger patients. What is known already Ovarian stromal fibrosis increases with aging and is associated with impaired ovarian function through reduced elasticity and vascularization. Chemotherapy and radiotherapy are established causes of gonadotoxicity and loss of ovarian reserve. Ovarian tissue cryopreservation is widely used for fertility preservation, particularly in pediatric and young adult cancer patients. However, the histological and molecular effects of anti-tumor therapy on ovarian stroma remain poorly understood. Study design, size, duration This retrospective observational study analyzed ovarian tissue collected for fertility preservation between January 2015 and March 2024. Twenty-nine patients undergoing laparoscopic unilateral oophorectomy for ovarian tissue cryopreservation were included. Also, two young ovarian cancer patients who receive interval debulking surgery after primary debulking surgery and adjuvant chemotherapy were included for spatial transcriptome analysis. Participants/materials, setting, methods Remnant ovarian tissues submitted for pathological assessment of minimal residual disease were examined. Stromal fibrosis was visualized using Masson’s trichrome staining and quantified with ImageJ/FIJI software. Fibrotic areas were compared between patients with and without prior chemotherapy and/or radiotherapy. In addition, spatial transcriptomic analysis using non-neoplastic area in ovarian tissue of young ovarian cancer patients before and after chemotherapy were performed to assess the effect of chemotherapy on ovarian stroma. Main results and the role of chance Among the 29 patients, 18 had received chemotherapy and/or radiotherapy prior to ovarian cryopreservation, while 11 underwent the procedure before initiating cancer treatment. The median age of the exposed group was 16.3 years (SD 4.3), compared with 25.0 years (SD 7.7) in the unexposed group. Despite their younger age, the exposed group exhibited a significantly higher proportion of ovarian stromal fibrosis (p < 0.01), indicating that the observed difference was unlikely to be attributable to aging alone. Spatial transcriptomic analysis suggested therapy-associated spatial gene expression changes related to extracellular matrix remodeling and fibroblast activation. These findings provide molecular support for the observed histological increase in stromal fibrosis. Limitations, reasons for caution This study is limited by its retrospective design and small sample size. Reproductive outcomes after ovarian tissue transplantation were not evaluated. Wider implications of the findings Integrating histological fibrosis assessment with spatial transcriptomic profiling may improve understanding of treatment-induced ovarian damage and aid prognostication of cryopreserved ovarian tissue function. Trial registration number No

Zitieren

APA

Iyoshi, S., Miyake, N., Fujimoto, H., Kamiya, C., Shibata, T., Akita, H., Kawai, K., Ueda, M., Furui, K., Takeda, T., Seki, T., Reina, S., Muraoka, A., Nakamura, T., & Kajiyama, H. (2026). L26/P-415 Association between ovarian stromal fibrosis and prior anti-tumor therapy in cryopreserved ovarian tissue. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.749

Vancouver

Iyoshi S, Miyake N, Fujimoto H, Kamiya C, Shibata T, Akita H, et al. L26/P-415 Association between ovarian stromal fibrosis and prior anti-tumor therapy in cryopreserved ovarian tissue. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.749

BibTeX
@article{Iyoshi2026,
  author = {Iyoshi, S. and Miyake, N. and Fujimoto, H. and Kamiya, C. and Shibata, T. and Akita, H. and Kawai, K. and Ueda, M. and Furui, K. and Takeda, T. and Seki, T. and Reina, S. and Muraoka, A. and Nakamura, T. and Kajiyama, H.},
  title = {L26/P-415 Association between ovarian stromal fibrosis and prior anti-tumor therapy in cryopreserved ovarian tissue},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.749}
}
Kostenlos starten →